Generalized cellular hypertrophy is induced by a dual-acting PPAR agonist in rat urinary bladder urothelium in vivo.
about
Tissue distribution of human AKR1C3 and rat homolog in the adult genitourinary systemMedicinal Chemistry and Actions of Dual and Pan PPAR Modulators.Idealized PPARγ-Based Therapies: Lessons from Bench and BedsidePPARgamma and MEK Interactions in CancerRat Urinary Bladder Carcinogenesis by Dual-Acting PPARalpha + gamma AgonistsDeciphering the Roles of Thiazolidinediones and PPARγ in Bladder Cancer.Peroxisome proliferator-activated receptor agonists and bladder cancer: lessons from animal studies.Refocusing Peroxisome Proliferator Activated Receptor-α: A New Insight for Therapeutic Roles in Diabetes.Critical analysis of carcinogenicity study outcomes. Relationship with pharmacological properties.PPAR alpha and PPAR gamma coactivation rapidly induces Egr-1 in the nuclei of the dorsal and ventral urinary bladder and kidney pelvis urothelium of rats.Urothelial carcinogenesis in the urinary bladder of rats treated with naveglitazar, a gamma-dominant PPAR alpha/gamma agonist: lack of evidence for urolithiasis as an inciting event.Proliferative and nonproliferative lesions of the rat and mouse urinary system.Trans-species comparison of PPAR and RXR expression by rat and human urothelial tissues.Urothelial carcinogenesis in the urinary bladder of male rats treated with muraglitazar, a PPAR alpha/gamma agonist: Evidence for urolithiasis as the inciting event in the mode of action.Pioglitazone Use and Risk of Bladder Cancer: an In Vitro Study.
P2860
Q24328776-F4E85D52-ABAF-43F3-9EDD-A6C7C8C213B8Q35216684-4E91AFCF-5F51-4306-ADB1-F08672700E09Q36056207-84404DA1-42B3-4B4D-9511-2675FADC660FQ36737285-1EA4C3D6-8BB4-4A1D-824D-64578C6D3912Q37077098-7B32864D-BC64-455A-9A20-D20A2EE2A5D6Q37699907-B5213BE3-FEBB-4636-B9D6-9BE05755EA13Q38061184-BFA2C6FD-3352-440F-AE15-1750B6A237DBQ38160494-1F070F78-0D2A-4C46-B0D3-4E63820C4CF5Q38818082-67F10382-7E18-43C1-BAEC-60C59380D8B8Q43222810-6371B9EA-3BDF-449B-9D3D-C46ADD4BBEF0Q46599209-8B5A8824-5F7D-40FA-AC9D-A602748BBE6BQ48636042-80F32CDD-6D6B-4DCA-9F2F-34F3A14BAF2AQ53321831-C2ED930D-CA91-4C5F-BA1E-F34679177932Q53338744-AA2D0FCE-4CD1-4F1A-9B2A-BCA19F59C149Q55356554-823D82BA-38AE-4005-9FEF-668D4AD9CA2A
P2860
Generalized cellular hypertrophy is induced by a dual-acting PPAR agonist in rat urinary bladder urothelium in vivo.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Generalized cellular hypertrop ...... ry bladder urothelium in vivo.
@en
Generalized cellular hypertrop ...... ry bladder urothelium in vivo.
@nl
type
label
Generalized cellular hypertrop ...... ry bladder urothelium in vivo.
@en
Generalized cellular hypertrop ...... ry bladder urothelium in vivo.
@nl
prefLabel
Generalized cellular hypertrop ...... ry bladder urothelium in vivo.
@en
Generalized cellular hypertrop ...... ry bladder urothelium in vivo.
@nl
P2093
P2860
P1476
Generalized cellular hypertrop ...... ry bladder urothelium in vivo.
@en
P2093
Anne Charlotte Hegelund
Hanne V Andersen
Henriette S Nielsen
Inger Thorup
Ingrid Sjogren
Lars Iversen
Lis Jørgensen
Marianne B Jensen
Martin B Oleksiewicz
Peter R Brinck
P2860
P304
P356
10.1080/01926230500214657
P407
P577
2005-01-01T00:00:00Z